Guest Editors
Prof. Lingbin Meng
Email: Lingbin.Meng@osumc.edu
Affiliation: Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.
Homepage:
Research Interests: bladder cancer, kidney cancers, testicular cancers, prostate cancers, urogenital cancers
Summary
This special issue will highlight recent advances in the multidisciplinary management of genitourinary cancers, with a focus on integrating clinical innovation into real-world practice. Topics could include surgical advancements and their coordination with systemic therapies, modern radiotherapy techniques, and the implementation of translational biomarkers in routine care. The issue will also explore the evolving role of immunotherapy and emerging cell-based therapies, while addressing patient-centered outcomes such as survivorship, quality of life, and treatment-related disparities. Together, these articles will provide a comprehensive overview of how novel approaches are reshaping the landscape of urologic oncology.
Potential scope and topics to be covered include:
· Surgical Advances and Integration with Systemic Therapies in Genitourinary Cancers
· Evolving Radiotherapy Strategies in Genitourinary Malignancies
· Real-World Treatment Patterns and Care Disparities in Urologic Oncology
· Supportive Care, Survivorship, and Patient-Reported Outcomes in GU Cancer Management
· Translational Biomarkers with Clinical Utility in Prostate, Bladder, testicular, penile and Kidney Cancer
· Emerging Cell-Based Therapies and Engineered Immune Platforms in Urologic Oncology
Keywords
genitourinary cancer, immunotherapy, biomarkers, surgery, radiotherapy, cell therapy, real-world data, survivorship, quality of life, treatment disparities
Login
Register
Submit a Paper
Propose a Special lssue